HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical case of the...
"ORHub continues to evaluate synergistic opportunities which add revenue and broaden market opportunity." IRVINE, CA / ACCESSWIRE / March 7, 2022 / ORHub, Inc. (OTC PINK:ORHB). ORHub today announced it is actively...
TALLAHASSEE, Fla.--(BUSINESS WIRE)--VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its LumiVy Lumbar IBF System which...
The first AI-powered video management and analytics platform for the OR, Touch Surgery Enterprise gives surgical teams easy access to procedural videos and insights DUBLIN, March 9, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT),...
MACON, Ga.--(BUSINESS WIRE)--Southern Spine, LLC, an ISO 13485:2016 certified manufacturer of implants and instruments for spinal surgery based in Macon, Georgia, announces that it has formed its first Center of...
Swiss company to expand in US marketplace BASEL, SWITZERLAND (PRWEB) MARCH 07, 2022 Medartis, a Swiss-based orthopedic company for head and extremity surgery, has announced its intent to acquire Nextremity Solutions, Inc., a...
Alfonso Cloud brings time-saving convenience and reliability to implant design process. Hong Kong SAR, March 7th, 2022 - Lifespans today announced the launch of Alfonso Cloud, a self-service portal for implant...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era...
Innovation and new product launches fuel continued revenue growth. DALLAS, Feb. 24, 2022 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design utilizing its...
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection; improvements...